CrushSCI.com
提供学术论文选刊润色服务
BRITISH JOURNAL OF CANCER 期刊封面 医学
返回期刊列表

Review Cycle Records

BRITISH JOURNAL OF CANCER

Springer SCIE 非OA
2026新锐 1区2025中科院 2区 TOP2025 JCR Q1
153.6平均天数
146中位天数
29最短天数
343最长天数
3732025发文量

Paper Review Records

全部论文审稿周期

17 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

105 天

Paediatric Therapeutic Development Workshop on rhabdomyosarcoma

作者Joseph S. Baxter; Claudia Montiel Equihua; Jan J. Molenaar; Jamie Aye; Gianni Bisogno; Patricia Blanc; Willemijn Breunis; Julia Chisholm; Jacquelyn Crane; Sam Daems; Laura Danielson; Bram de Wilde; Adam D. Durbin; Felipe Galvez-Cancino; Patrizia Gasparini; Birgit Geoerger; Simone Graham; Bass Hassan; Mark E. Hatley; Delphine Heenen; Christine M. Heske; Simone Hettmer; Elizabeth Hookham; Peter Houghton; Pamela Kearns; Charles Keller; Javed Khan; Fiona Kinnis; David Langenau; Geffen Lass; Corinne Mary Linardic; Leo Mascarenhas; Michael T. Meister; Jonathan Metts; Véronique Minard-Colin; Sapna Oberoi; Daniela Palacios; Abbe Pannucci; Seema Patel; Sheena Patel; Silvia Pomella; Terry Rabbitts; Rossella Rota; Erin Rudzinski; Beat Schäfer; John Jack Shern; Karin Straathof; Rajkumar Venkatramani; Marco Wachtel; Sara Wakeling; Zoë Walters; Sam Warburton; Brenda Weigel; Andrew D. J. Pearson; David Jenkinson; Janet Shipley; Michela Casanova

作者单位1. LifeArc, London, UK; 2. Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; 3. The University of Alabama at Birmingham, Birmingham, USA; 4. Department of Women’s and Children’s Health, University of Padova and Pediatric Hematology Oncology Unit, University Hospital of Padova, Padua, Italy; 5. Imagine for Margo, Paris, France; 6. University Children’s Hospital Zurich, Zürich, Switzerland; 7. The Royal Marsden Hospital and Institute of Cancer Research, Sutton, UK; 8. Children’s Hospital of Philadelphia, Philadelphia, USA; 9. Waterland Private Equity Investments, Antwerp, Belgium; 10. I3h Institute, Université libre de Bruxelles, Brussels, Belgium; 11. Cancer Research UK, London, UK; 12. Ghent University Hospital, Gent, Belgium; 13. St Jude Children’s Research Hospital, Memphis, USA; 14. Laboratory of Immune-Regulation, Centre for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford, Oxford, UK; 15. Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy; 16. Gustave Roussy, Paris, France; 17. Sir William Dunn School of Pathology, University of Oxford, Oxford, UK; 18. KickCancer Foundation, Brussels, Belgium; 19. Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA; 20. Pediatrics I, Martin-Luther University Halle-Wittenberg, Halle, Germany; 21. UT Health San Antonio, San Antonio, USA; 22. College of Medicine and Health, University of Birmingham, Birmingham, UK; 23. Innovative Therapies for Children and Adolescents with Cancer (ITCC), Paris, France; 24. Children’s Cancer Therapy Development Institute, Hillsboro, USA; 25. Oncogenomics Section, Genetics Branch, Centre for Cancer Research, National Cancer Institute, Bethesda, USA; 26. Massachusetts General Hospital - Charlestown Navy Yard (CNY) Campus, Charlestown, USA; 27. Department of Pediatrics, Duke University School of Medicine, LSRC, Durham, USA; 28. Cedars Sinai, Los Angeles, USA; 29. Johns Hopkins All Children’s Cancer & Blood Disorders Institute, Saint Petersburg, USA; 30. Max Rady College of Medicine, Pediatrics and Child Health, CancerCare Manitoba, University of Manitoba, Winnipeg, Canada; 31. Institute for Systems Analysis and Computer Science “Antonio Ruberti” (IASI), National Research Council (CNR), Rome, Italy; 32. Alice’s Arc, New York City, USA; 33. Cancer Research Horizons, London, UK; 34. Bambino Gesu’ Children’s Hospital, IRCCS, Rome, Italy; 35. The Institute of Cancer Research, Brookes Lawley Building, Centre for Cancer Drug Discovery, Sutton, UK; 36. Indiana University School of Medicine, Indianapolis, USA; 37. Universitäts-Kinderspital Zürich, Eleonorenstiftung, Zürich, Switzerland; 38. Cancer Research, National Cancer Institute, Bethesda, USA; 39. University College London Cancer Institute, Great Ormond Street Biomedical Research Centre, London, UK; 40. Texas Children’s Hospital, Houston, USA; 41. Alice’s Ark, Children’s Cancer Charity, Sevenoaks, UK; 42. Southampton General Hospital, University of Southampton, Southampton, UK; 43. The Institute of Cancer Research, London, UK

PDF源文件 DOI 网页
44 天

Risk-based breast cancer screening

作者Stig Egil Bojesen

作者单位1. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; 2. Department of Clinical Biochemistry, Copenhagen University Hospital, Herlev Gentofte, Copenhagen, Denmark

PDF源文件 DOI 网页
137 天

Next-generation models for lymphoid malignancies: the rise of 3D culture systems in translational hematology

作者Narimène Houmera; Laurent Genestier; Sarah Huet

作者单位1. Team Lymphoma Immuno-Biology, Centre International de Recherche en Infectiologie, Lyon, France; 2. Institut des Sciences Pharmaceutiques et Biologiques, Université Claude Bernard Lyon 1, Lyon, France; 3. Service d’hématologie biologique, Hôpital Lyon Sud, Hospices Civils de Lyon, Lyon, France

PDF源文件 DOI 网页
206 天

Beyond borders: advancing oncology trials

作者Milit S. Patel; Jeffrey Shi Kai Chan; Nina N. Sanford; Jonas Willmann; Puneeth Iyengar; Edward Christopher Dee

作者单位1. Department of Molecular Biosciences, The University of Texas at Austin, Austin, USA; 2. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, USA; 3. Cardio-Oncology Research Unit, Cardiovascular Analytics Group, School of Nursing and Health Sciences, Hong Kong Metropolitan University, Hong Kong, China; 4. Department of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, USA; 5. Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA; 6. Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland

PDF源文件 DOI 网页
144 天

Multi-scale transcriptomic integration reveals LINC00152-high tumor cells promote TGCT progression and T cell exhaustion

作者Jian Cao; Fang Zhu; Kongrong Xu; Zhizhong Liu; Lei Chen; Shanshan Lv; Liqing Fan; Jie Guo; Mina Tao; Yanwei Luo; Guoli Li; Hao Bo

作者单位1. Department of Urology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China; 2. NHC Key Laboratory of Human Stem Cell and Reproductive Engineering, Institute of Reproductive and Stem Cell Engineering, Xiangya School of Basic Medical Science, Central South University, Changsha, China; 3. Department of Reproductive Medicine, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China; 4. Department of Blood Transfusion, The Third Xiangya Hospital, Central South University, Changsha, China; 5. Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha, China; 6. National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, China; 7. Department of Nephrology, Hunan Clinical Research Center for Chronic Kidney Disease, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China; 8. Hunan Engineering Research Center for Prevention, Treatment and Rehabilitation of Kidney Diseases, Changsha, China; 9. Changsha Innovation Center for Integrated Diagnosis and Treatment Technology of Metabolic dysfunction–associated kidney diseases, Changsha, China

PDF源文件 DOI 网页
163 天

Primary tumour resection in de novo stage IV breast cancer: considerations from the PRIM-BC trial

作者Ahmad Kaviani; Neda Karkeabadi; Borna Farazmand

作者单位1. Centre hospitalier de l’Université de Montréal, Department of Surgery- Surgical Oncology Service, Montreal, Canada; 2. Breast Diseases Research Center (BDRC), Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran; 3. Department of Surgical Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran; 4. Radiation Oncology Research Center (RORC), Cancer Research Institute, Tehran University of Medical Sciences, Tehran, Iran

PDF源文件 DOI 网页
184 天

The brain-lung immunotherapy prognostic (BLIP) Score: a novel robust tool for prognostication in non-small cell lung cancer patients with brain metastases

作者Marcus Skribek; Maria-Effrosyni Livanou; Ioannis Vathiotis; Viktor Strandman; Axel Thorell; Andreas Koulouris; Konstantinos Syrigos; Simon Ekman; Georgios Tsakonas

作者单位1. Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; 2. Medical Unit Head-Neck, Lung, Skin Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden; 3. Third Department of Internal Medicine, Sotiria Thoracic Diseases Hospital of Athens, National and Kapodistrian University of Athens, Athens, Greece; 4. Laboratory of Translational Oncology, Medical School, University of Crete, Heraklion, Greece

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。